Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Sabina Sánchez Hernández"'
Publikováno v:
Frontiers in Genome Editing, Vol 4 (2022)
Defects in the DOCK8 gene causes combined immunodeficiency termed DOCK8 immunodeficiency syndrome (DIDS). DIDS previously belonged to the disease category of autosomal recessive hyper IgE syndrome (AR-HIES) but is now classified as a combined immunod
Externí odkaz:
https://doaj.org/article/c2ee6c3100f54fa1b3548f0898727f10
Autor:
Anders Laustsen, Renée M van der Sluis, Albert Gris-Oliver, Sabina Sánchez Hernández, Ena Cemalovic, Hai Q Tang, Lars Henning Pedersen, Niels Uldbjerg, Martin R Jakobsen, Rasmus O Bak
Publikováno v:
eLife, Vol 10 (2021)
Plasmacytoid dendritic cells (pDCs) constitute a rare type of immune cell with multifaceted functions, but their potential use as a cell-based immunotherapy is challenged by the scarce cell numbers that can be extracted from blood. Here, we systemati
Externí odkaz:
https://doaj.org/article/6f3798286f634c3eb305fef770b61810
Autor:
María Tristán-Manzano, Noelia Maldonado-Pérez, Pedro Justicia-Lirio, Pilar Muñoz, Marina Cortijo-Gutiérrez, Kristina Pavlovic, Rosario Jiménez-Moreno, Sonia Nogueras, M. Dolores Carmona, Sabina Sánchez-Hernández, Araceli Aguilar-González, María Castella, Manel Juan, Concepción Marañón, Juan Antonio Marchal, Karim Benabdellah, Concha Herrera, Francisco Martin
Publikováno v:
Molecular Therapy: Oncolytics, Vol 25, Iss , Pp 335-349 (2022)
Anti-CD19 chimeric antigen receptor (CAR)-T cells have achieved impressive outcomes for the treatment of relapsed and refractory B-lineage neoplasms. However, important limitations still remain due to severe adverse events (i.e., cytokine release syn
Externí odkaz:
https://doaj.org/article/c338abdeeff24c2185714739029ce627
Autor:
Cristina Cueto-Ureña, Enric Mocholí, Josep Escrivá-Fernández, Susana González-Granero, Sabina Sánchez-Hernández, Amalia Solana-Orts, Begoña Ballester-Lurbe, Karim Benabdellah, Rosa M. Guasch, José Manuel García-Verdugo, Francisco Martín, Paul J. Coffer, Ignacio Pérez-Roger, Enric Poch
Publikováno v:
Frontiers in Cell and Developmental Biology, Vol 10 (2022)
Autophagy is a highly conserved process that mediates the targeting and degradation of intracellular components to lysosomes, contributing to the maintenance of cellular homeostasis and to obtaining energy, which ensures viability under stress condit
Externí odkaz:
https://doaj.org/article/7de0449f54f5452689bd32359d3d685e
Autor:
Karim Benabdellah, Sabina Sánchez‐Hernández, Araceli Aguilar‐González, Noelia Maldonado‐Pérez, Alejandra Gutierrez‐Guerrero, Marina Cortijo‐Gutierrez, Iris Ramos‐Hernández, María Tristán‐Manzano, Pablo Galindo‐Moreno, Concha Herrera, Francisco Martin
Publikováno v:
Stem Cells Translational Medicine, Vol 9, Iss 6, Pp 674-685 (2020)
Abstract Over recent decades, gene therapy, which has enabled the treatment of several incurable diseases, has undergone a veritable revolution. Cell therapy has also seen major advances in the treatment of various diseases, particularly through the
Externí odkaz:
https://doaj.org/article/6ff4ed6867924111889b9c3c4cbf9775
Publikováno v:
Hernández, S S, Jakobsen, M R & Bak, R O 2022, ' Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy ', International Journal of Molecular Sciences, vol. 23, no. 19, 11397 . https://doi.org/10.3390/ijms231911397
Hernández, S S, Jakobsen, M R & Bak, R O 2022, ' Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy ', International journal of molecular sciences, vol. 23, no. 19 . https://doi.org/10.3390/ijms231911397
Hernández, S S, Jakobsen, M R & Bak, R O 2022, ' Plasmacytoid Dendritic Cells as a Novel Cell-Based Cancer Immunotherapy ', International journal of molecular sciences, vol. 23, no. 19 . https://doi.org/10.3390/ijms231911397
Plasmacytoid dendritic cells (pDCs) are multifaceted immune cells with a wide range of innate and adaptive immunological functions. They constitute the first line of defence against multiple viral infections and have also been reported to actively pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c3eafca9c6dfc8568b5699780854ace6
https://pubmed.ncbi.nlm.nih.gov/36232698
https://pubmed.ncbi.nlm.nih.gov/36232698
Autor:
Jesper Geert Pedersen, Kristine Raaby Gammelgaard, Jakob Thyrsted, Martin Tolstrup, Lamin B Cham, Ole S. Søgaard, Lasse Sommer Kristensen, Tobias W Bjerg, Stine Høvring Godsk, Anders Laustsen, Line S. Reinert, David Olagnier, Søren R. Paludan, Renée M. van der Sluis, Manja Idorn, Janni j Jorgensen, Alberg Gris Oliver, Mads Kjolby, Silke D Nielsen, Sabina Sánchez Hernández, Rasmus O. Bak, Ulvi Ahmodov, Christian K. Holm, Ena Cemalovic, Jesper Damsgaard Gunst, Martin R. Jakobsen
Understanding the molecular pathways driving the acute antiviral and inflammatory response to SARS-CoV-2 infection is critical for developing treatments for severe COVID-19. Here we show that in COVID-19 patients, circulating plasmacytoid dendritic c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f776416cf8fa82da3a7207b9af1466a4
https://doi.org/10.1101/2021.11.23.469755
https://doi.org/10.1101/2021.11.23.469755
Autor:
María Tristán-Manzano, Noelia Maldonado-Pérez, Pedro Justicia-Lirio, Pilar Muñoz, Marina Cortijo-Gutiérrez, Kristina Pavlovic, Rosario Jiménez-Moreno, Sonia Nogueras, M. Dolores Carmona, Sabina Sánchez-Hernández, Araceli Aguilar-González, María Castella, Manel Juan, Concepción Marañón, Juan Antonio Marchal, Karim Benabdellah, Concha Herrera, Francisco Martin
Publikováno v:
Molecular therapy oncolytics. 25
Anti-CD19 chimeric antigen receptor (CAR)-T cells have achieved impressive outcomes for the treatment of relapsed and refractory B-lineage neoplasms.However, important limitations still remain due to severe adverse events (i.e., cytokine release synd
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bd9e0c103b05c5628362ede499bcf60c
https://pubmed.ncbi.nlm.nih.gov/35919458
https://pubmed.ncbi.nlm.nih.gov/35919458
Autor:
Martin R. Jakobsen, Albert Gris-Oliver, Anders Laustsen, Niels Uldbjerg, Hai Q Tang, Lars Pedersen, Sabina Sánchez Hernández, Renée M. van der Sluis, Ena Cemalovic, Rasmus O. Bak
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ba1da4ba7a9739a4f82fd9b7ca93156e
https://doi.org/10.7554/elife.65528.sa2
https://doi.org/10.7554/elife.65528.sa2
Autor:
Pedro J. Real, Noelia Maldonado-Pérez, Marina Cortijo-Gutiérrez, Karim Benabdellah, Concha Herrera, Lourdes Lopez-Onieva, Francisco Martin, Sabina Sánchez-Hernández, María Tristán-Manzano, Juan A. Marchal
Publikováno v:
Pharmaceutics, Vol 13, Iss 1217, p 1217 (2021)
Pharmaceutics
Volume 13
Issue 8
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Pharmaceutics
Volume 13
Issue 8
Digibug. Repositorio Institucional de la Universidad de Granada
instname
This study was funded by the Spanish ISCIII Health Research Fund and the European Regional Development Fund (FEDER) through research grants PI12/01097, PI15/02015, PI18/00337 (F.M.) PIE16-00045 (J.A.M.), DTS19/00145 (J.A.M.), and PI18/00330 (K.B.) Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::305dea30998768ea3016f52d5d3f2e6c
https://www.mdpi.com/1999-4923/13/8/1217
https://www.mdpi.com/1999-4923/13/8/1217